ABL Bio Secures $55M from Eli Lilly to Accelerate Grabody Platform Expansion

- Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 million in equity investment - Accelerating R&D o...

December 29, 2025 | Monday | News
Flagship Pioneering and Pfizer Launch New Repertoire-Led Program to Develop TCR Bispecifics for Metastatic Prostate Cancer

Flagship Pioneering, a scientific innovation engine for transformative platforms and products, announced a research program under its strategic collabora...

December 25, 2025 | Thursday | News
datma and Rhythm Biosciences Launch Exploratory Collaboration to Advance Genomic-Integrated Cancer Risk Prediction

The two companies will explore how datma's federated ecosystem can support Rhythm Biosciences' diagnostic development efforts as they shape a future comm...

December 25, 2025 | Thursday | News
Wasatch BioLabs and Agilent Partner to Expand Access to Native-Read Targeted Methylation Sequencing

Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, announced a co-marketing agreement with Agilent Technologies to ...

December 23, 2025 | Tuesday | News
Parse Biosciences Partners With Codebreaker Labs to Crack Rare Variant Mapping at Single-Cell Scale

Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping...

December 22, 2025 | Monday | News
Harbour BioMed And Bristol Myers Squibb Forge Global Multi-Specific Antibody Alliance

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immuno...

December 18, 2025 | Thursday | News
Norgine Secures Exclusive Rights to Vir Biotechnology’s Hepatitis Delta Combination Therapy

Agreement underscores Norgine's mission to bring innovative therapies to patients and builds on our heritage in hepatology and specialty pharmaceutical...

December 18, 2025 | Thursday | News
Enko and Syngenta Advance First-in-Class Fungicide Chemistry to Field Trials

Enko Chem, Inc. announced  that a novel fungicide class of chemistry developed in collaboration with Syngenta Crop Protection has advanced to field ...

December 12, 2025 | Friday | News
Oxford BioTherapeutics and GSK Launch Multi-Year Collaboration to Develop Novel Antibody-Based Cancer Therapies

Collaboration leverages OBT's proprietary OGAP®-Verify platform and GSK's drug development expertise to advance multiple selected novel oncology ta...

December 11, 2025 | Thursday | News
Polpharma Biologics and Libbs Join Forces to Accelerate Biosimilar Availability for Autoimmune Diseases

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the si...

December 11, 2025 | Thursday | News
Akadeum Launches CDMO Alliance With ElevateBio and Charles River as Inaugural Members

Cell therapy manufacturers Charles River and ElevateBio are named as inaugural members Akadeum Life Sciences, the leader in buoyant cell separation, ann...

December 10, 2025 | Wednesday | News
GlycoNex Enters CDMO Agreement to Advance First-in-Class Anti-HMGB1 Antibody Into Clinical Trials in Japan

Collaboration with Science Tokyo spinout underscores GlycoNex's integrated antibody development and manufacturing capabilities in support of first-in-cla...

December 09, 2025 | Tuesday | News
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Tumor Profiling Program to China

Pillar Biosciences and AstraZeneca announced an expansion of their existing laboratory access program for NGS-based kitted liquid biopsy tumor profi...

December 09, 2025 | Tuesday | News
Quotient Sciences Announces Strategic Multi-Year Partnership with Intrepid Labs to Accelerate AI-Driven Early Drug Development

Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical formulat...

December 08, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close